74 related articles for article (PubMed ID: 20814188)
1. National audit of patient choice in pediatric GH therapy.
Langham S; Kirk J;
Horm Res Paediatr; 2011 Feb; 75(2):101-5. PubMed ID: 20814188
[TBL] [Abstract][Full Text] [Related]
2. Specialist services and transitional care in paediatric endocrinology in the UK and Ireland.
Kirk J; Clayton P
Clin Endocrinol (Oxf); 2006 Jul; 65(1):59-63. PubMed ID: 16817820
[TBL] [Abstract][Full Text] [Related]
3. Factors determining patient choice of device for GH therapy.
Wickramasuriya BP; Casey A; Akhtar S; Zia R; Ehtisham S; Barrett TG; Shaw NJ; Kirk JM
Horm Res; 2006; 65(1):18-22. PubMed ID: 16357486
[TBL] [Abstract][Full Text] [Related]
4. Improving adherence to GH therapy with an electronic device: first experience with easypod.
Kirk J
Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():549-52. PubMed ID: 19550392
[TBL] [Abstract][Full Text] [Related]
5. Indications for growth hormone therapy in children.
Kirk J
Arch Dis Child; 2012 Jan; 97(1):63-8. PubMed ID: 21540481
[TBL] [Abstract][Full Text] [Related]
6. The boom that never was: results of a 10 year audit of paediatric growth hormone prescribing in Scotland.
Paterson WF; Donaldson MD; Greene SA; Kelnar CJ; Smail PJ
Health Bull (Edinb); 2000 Nov; 58(6):457-66. PubMed ID: 12813777
[TBL] [Abstract][Full Text] [Related]
7. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
Hardin DS; Woo J; Butsch R; Huett B
Clin Endocrinol (Oxf); 2007 Jan; 66(1):85-94. PubMed ID: 17201806
[TBL] [Abstract][Full Text] [Related]
8. A web-based survey assessing the impact of storage flexibility on the daily life of patients and caregivers administering growth hormone.
Kappelgaard AM; Metzinger CP; Schnabel D
Expert Rev Med Devices; 2015; 12(5):517-27. PubMed ID: 26186495
[TBL] [Abstract][Full Text] [Related]
9. Survey of growth hormone treatment practices by 251 pediatric endocrinologists.
Wyatt DT; Mark D; Slyper A
J Clin Endocrinol Metab; 1995 Nov; 80(11):3292-7. PubMed ID: 7593441
[TBL] [Abstract][Full Text] [Related]
10. Short stature and growth hormone therapy. A national study of physician recommendation patterns.
Cuttler L; Silvers JB; Singh J; Marrero U; Finkelstein B; Tannin G; Neuhauser D
JAMA; 1996 Aug; 276(7):531-7. PubMed ID: 8709401
[TBL] [Abstract][Full Text] [Related]
11. Survey of psychosocial support provided by UK paediatric oncology centres.
Mitchell W; Clarke S; Sloper P
Arch Dis Child; 2005 Aug; 90(8):796-800. PubMed ID: 15855177
[TBL] [Abstract][Full Text] [Related]
12. Wide variation in surgical outcomes for acromegaly in the UK.
Bates PR; Carson MN; Trainer PJ; Wass JA;
Clin Endocrinol (Oxf); 2008 Jan; 68(1):136-42. PubMed ID: 17803712
[TBL] [Abstract][Full Text] [Related]
13. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
[TBL] [Abstract][Full Text] [Related]
14. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the quality of patient leaflets about renal replacement therapy across UK renal units.
Winterbottom A; Conner M; Mooney A; Bekker HL
Nephrol Dial Transplant; 2007 Aug; 22(8):2291-6. PubMed ID: 17369614
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of acute subdural haematomas: current practice patterns in the United Kingdom and the Republic of Ireland.
Kolias AG; Scotton WJ; Belli A; King AT; Brennan PM; Bulters DO; Eljamel MS; Wilson MH; Papadopoulos MC; Mendelow AD; Menon DK; Hutchinson PJ; ;
Br J Neurosurg; 2013 Jun; 27(3):330-3. PubMed ID: 23530712
[TBL] [Abstract][Full Text] [Related]
17. Current UK practice of pediatric supraglottic airway devices - a survey of members of the Association of Paediatric Anaesthetists of Great Britain and Ireland.
Bradley AE; White MC; Engelhardt T; Bayley G; Beringer RM
Paediatr Anaesth; 2013 Nov; 23(11):1006-9. PubMed ID: 23909988
[TBL] [Abstract][Full Text] [Related]
18. Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay.
Meinhardt U; Eiholzer U; Seitz L; Bøgelund M; Kappelgaard AM
Expert Rev Med Devices; 2014 Jan; 11(1):31-8. PubMed ID: 24308742
[TBL] [Abstract][Full Text] [Related]
19. An audit of growth hormone replacement for GH-deficient adults in Scotland.
Philip S; Howat I; Carson M; Booth A; Campbell K; Grant D; Patterson C; Schofield C; Bevan J; Patrick A; Leese G; Connell J
Clin Endocrinol (Oxf); 2013 Apr; 78(4):571-6. PubMed ID: 22901318
[TBL] [Abstract][Full Text] [Related]
20. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
